Attachment of poly(ethylene glycol) (PEG) to proteins, peptides, liposomes, drugs, and nanoparticles can improve pharmaceutical pharmacokinetic properties and enhance in vivo biological efficacy. Since the first PEGylated product was approved by the Food and Drug Administration in 1990, increasing numbers of PEGylated compounds have entered clinical use. Successful clinical development of PEGylated pharmaceuticals requires accurate methods for the qualitative and quantitative analysis of intact PEG conjugates in biological fluids. In this article, we review assay methods that can be utilized for the detection and measurement of PEGylated pharmaceuticals in complex biological samples for determination of biodistribution and pharmacokinetic properties. In particular, we describe relevant colorimetric, chromatographic, radiolabeled, biological, and enzyme-linked immunosorbent assays for the pharmacokinetic study of PEGylated molecules. © 2012 American Chemical Society.
CITATION STYLE
Cheng, T. L., Chuang, K. H., Chen, B. M., & Roffler, S. R. (2012, May 16). Analytical measurement of pegylated molecules. Bioconjugate Chemistry. American Chemical Society. https://doi.org/10.1021/bc200478w
Mendeley helps you to discover research relevant for your work.